Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 2/3 1

Status

Completed 13Unknown 8Recruiting 8Active not recruiting 6Withdrawn 2Terminated 2Not yet recruiting 2

Sponsor Class

OTHER 8

Study Type

Observational 4Interventional 4

Sponsor

Cancer Type

Gastrointestinal 8

Conditions

Breast Neoplasms 1477Neoplasms 999Colorectal Neoplasms 832Carcinoma, Non-Small-Cell Lung 724Carcinoma, Hepatocellular 683Stomach Neoplasms 648Lung Neoplasms 584Prostatic Neoplasms 543Pancreatic Neoplasms 456Rectal Neoplasms 339Uterine Cervical Neoplasms 303Colonic Neoplasms 295Neoplasm Metastasis 294Ovarian Neoplasms 285Esophageal Neoplasms 279Recurrence 278Leukemia, Myeloid, Acute 253Head and Neck Neoplasms 241Multiple Myeloma 232Brain Neoplasms 204Polycystic Ovary Syndrome 200Nasopharyngeal Carcinoma 198Melanoma 198Precursor Cell Lymphoblastic Leukemia-Lymphoma 195Urinary Bladder Neoplasms 193Lymphoma 178Liver Neoplasms 178Endometrial Neoplasms 159Motor Activity 147Lymphoma, Large B-Cell, Diffuse 141

Interventions

irinotecan sucrosofate 1folfirinox 1Taxes 1Surgical Procedures, Operative 1Radiotherapy 1Radiosurgery 1Oxaliplatin 1Leucovorin 1Gemcitabine 1Folfox protocol 1Fluorouracil 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Unknown × OTHER × Pancreatic Adenocarcinoma × Clear all
NCT04143152 2024-04-23

Pancreatic Cancer Biomarker Study

Van Andel Research Institute

Unknown
300 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT05181605 2022-08-09

Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors

Instituto de investigación e innovación biomédica de Cádiz

Phase 2/3 Unknown
116 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT02839343 2022-05-24

Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Unknown
126 enrolled 12 charts
Gastrointestinal

Pancreatic Adenocarcinoma

NCT03528785 2021-08-02

nITRo

Centro Ricerche Cliniche di Verona

Phase 2 Unknown
67 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT04835064 2021-04-08

Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.

Fudan University

Phase 3 Unknown
600 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT04814251 2021-03-24

THROMPAN

Poitiers University Hospital

Unknown
200 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT03840460 2020-02-20

PaC-MAn

Royal Marsden NHS Foundation Trust

Unknown
200 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT03673423 2018-12-13

OBTCPAN

Ospedale San Raffaele

Unknown
138 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡